This Article Full Text Full Text (PDF) Correction Correction (v117,pe11) All Versions of this Article: 116/21/2399    most recent CIRCULATIONAHA.107.706523v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nagayama, T. Articles by Kass, D. A. Search for Related Content PubMed PubMed Citation Articles by Nagayama, T. Articles by Kass, D. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Related Collections Contractile function Myocardial cardiomyopathy disease Genetically altered mice

(Circulation. 2007;116:2399-2408.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Control of In Vivo Contraction/Relaxation Kinetics by Myosin Binding Protein C

Protein Kinase A Phosphorylation–Dependent and –Independent Regulation

Takahiro Nagayama, PhD; Eiki Takimoto, MD, PhD; Sakthivel Sadayappan, PhD; James O. Mudd, MD; J.G. Seidman, PhD; Jeffrey Robbins, PhD; David A. Kass, MD

From the Division of Cardiology, Department of Medicine (T.N., E.T., J.O.M., D.A.K.), Johns Hopkins Medical Institutions, Baltimore, Md; the Department of Pediatrics, Division of Molecular Cardiovascular Biology (S.S., J.R.), Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; and the Department of Genetics (J.G.S.), Harvard Medical School, Boston, Mass.

Correspondence to Dr David A. Kass, Division of Cardiology, Johns Hopkins Medical Institutions, Ross Research Building, Room 835, 720 Rutland Ave, Baltimore, MD 21205. E-mail dkass{at}jhmi.edu

Received March 29, 2007; accepted September 6, 2007.

Background— Cardiac myosin binding protein-C (cMyBP-C) is a thick-filament protein whose presence and phosphorylation by protein kinase A (PKA) regulates cross-bridge formation and kinetics in isolated myocardium. We tested the influence of cMyBP-C and its PKA-phosphorylation on contraction/relaxation kinetics in intact hearts and revealed its essential role in several classic properties of cardiac function.

Methods and Results— Comprehensive in situ cardiac pressure–volume analysis was performed in mice harboring a truncation mutation of cMyBP-C (cMyBP-C^(t/t)) that resulted in nondetectable protein versus hearts re-expressing solely wild-type (cMyBP-C^WT:(t/t)) or mutated protein in which known PKA-phosphorylation sites were constitutively suppressed (cMyBP-C^AllP-:(t/t)). Hearts lacking cMyBP-C had faster early systolic activation, which then terminated prematurely, limiting ejection. Systole remained short at faster heart rates; thus, cMyBP-C^(t/t) hearts displayed minimal rate-dependent decline in diastolic time and cardiac preload. Furthermore, prolongation of pressure relaxation by afterload was markedly blunted in cMyBP-C^(t/t) hearts. All 3 properties were similarly restored to normal in cMyBP-C^WT:(t/t) and cMyBP-C^AllP-:(t/t) hearts, which supports independence of PKA-phosphorylation. However, the dependence of peak rate of pressure rise on preload was specifically depressed in cMyBP-C^AllP-:(t/t) hearts, whereas cMyBP-C^(t/t) and cMyBP-C^AllP-:(t/t) hearts had similar blunted adrenergic and rate-dependent contractile reserve, which supports linkage of these behaviors to PKA-cMyBP-C modification.

Conclusions— cMyBP-C is essential for major properties of cardiac function, including sustaining systole during ejection, the heart-rate dependence of the diastolic time period, and relaxation delay from increased arterial afterload. These are independent of its phosphorylation by PKA, which more specifically modulates early pressure rise rate and adrenergic/heart rate reserve.

---

 

CLINICAL PERSPECTIVE